Brokerages Set Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Price Target at $9.83
Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) have been given a consensus rating of “Buy” by the nine brokerages that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, six have given a buy recommendation and two have assigned a strong buy […]
Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) have been given a consensus rating of “Buy” by the nine brokerages that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, six have given a buy recommendation and two have assigned a strong buy […]
